New spontaneous and carcinogen-induced mouse-derived isograft (MDI) tumor models for immune therapeutic approaches by Reaction Biology | Jul 6, 2023
All-in-one flow cytometry staining panel for immune-cell profiling in syngeneic tumor models by Reaction Biology | Jul 6, 2023
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models. Cancer Research Communications, 2022 by Reaction Biology | Jul 6, 2023
